基于药品质量提升的价格制度性影响因素分析

发布时间：2018-01-09 18:25

本文关键词：基于药品质量提升的价格制度性影响因素分析　出处：《中国药学杂志》2015年01期 　论文类型：期刊论文

【摘要】：目的探索影响药品质量提升的价格制度性因素,促进药品质量与药品价格关联的合理性回归。方法厘清药品质量内涵、药品质量与药品价格关系,通过基于专家访谈的结果编制调查问卷并对药品价格25个制度性影响因素进行描述统计和结构方程模型分析。结果药品价格影响药品质量提升的问题,不是完全由药品价格规制所决定,药品商业贿赂、药品流通环节多和费用多、能否进入医保报销目录、企业内部成本管理制度等问题是影响价格政策发挥作用的关键性因素。结论价格规制政策调整的方向,要以理顺企业内部成本管理制度为重点,对企业内部培训再教育、节能减排和仿制药质量一致性评价等方面给予价格政策鼓励,可弥补医药企业提升药品质量动力不足的问题。
[Abstract]:Objective to explore the institutional factors affecting drug quality improvement and to promote the rational regression between drug quality and drug price. Methods to clarify the connotation of drug quality and the relationship between drug quality and drug price. Based on the results of expert interviews, the questionnaire was compiled and 25 institutional factors of drug price were described, statistics and structural equation model were analyzed. Not entirely determined by the regulation of drug prices, drug commercial bribery, drug circulation links and costs, whether to enter the medical insurance reimbursement directory. The internal cost management system is the key factor that affects the effect of price policy. Conclusion the adjustment of price regulation policy should focus on straightening out the internal cost management system. Giving price policy encouragement to internal training and re-education, energy saving and emission reduction, and evaluation of generic drug quality consistency can make up for the insufficient power of pharmaceutical enterprises to improve drug quality.
【作者单位】：浙江医药高等专科学校;北京大学;
【基金】：国家社会科学基金资助项目(编号:13BGL141)
【分类号】：R956
【正文快照】： 药品价格和药品质量是医药产业健康发展不可或缺的2个方面。但是,当前国内医药市场的药品价格与药品质量往往不相关联,出现了药品流通环节较多、各环节加价过高、高价药驱逐低价药和市场上价格越低越滞销等诸多问题。2009年新医改政策、2011年和2012年医药卫生领域的“十二五

【参考文献】